Buscar
01/01/2023
"Acute kidney injury in critically ill patients with COVID-19: The AKICOV multicenter study in Catalonia"
De La Vega Sánchez A., Pérez A.N., Pérez-Carrasco M., Sonet M.T., Buendia Y.D., Ballujera P.O., López M.R., Riera J.S., Olmo-Isasmendi A., Torra E.V., García-Pumarino M.A., Villamayor M.I., Ibars R.M.C., Zelaya I.O., Chica J.P., Anglès C.R., Tomasa-Irriguible T.M., Serra A.B., Casanova E.J., González De Molina F.J.. "Acute kidney injury in critically ill patients with COVID-19: The AKICOV multicenter study in Catalonia". PLoS One. 2023; 18(4)DOI:10.1371/journal.pone.0284248. PMID:37058544. IF:2.900(Q1/3D).
01/01/2023
The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.
Sampedro F. The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 234DOI:10.1016/j.clineuro.2023.107990. PMID:37806052. IF:1.800(Q2/5D).
01/01/2023
Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease
Ortiz, A, Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease. NEFROLOGIA. 2023; 43(1)DOI:10.1016/j.nefro.2022.07.002. PMID:37217372. IF:2.000(Q2/5D).
01/01/2023
Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders
Segal A., Parkes L., Aquino K., Kia S.M., Wolfers T., Franke B., Hoogman M., Beckmann C.F., Westlye L.T., Andreassen O.A., Zalesky A., Harrison B.J., Davey C.G., Soriano-Mas C., Cardoner N., Tiego J., Yücel M., Braganza L., Suo C., Berk M., Cotton S., Bellgrove M.A., Marquand A.F., Fornito A.. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9)DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:21.300(Q1/1D).
01/01/2023
Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease
Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).
01/01/2023
The polygenic basis of relapse after a first episode of schizophrenia
Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).